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April 20111164 Letters to the Editorinterventions are likely to be most effective in this challenging
setting.
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Regarding “An analysis of relationship between
quality of life indices and clinical improvement
following intervention in patients with intermittent
claudication due to femoropopliteal disease”
We would like to complement Dr Mazari et al1 for their strict
follow-up and large sample size in their study of correlation be-
tween quality of life (QoL) instruments and clinical improvement
following intervention in patients with intermittent claudication
(IC) due to superficial femoral artery disease.
The study was presented as a prospective observational study
of patients recruited from an ongoing randomized controlled trial
(RCT) comparing supervised exercise, angioplasty, and combined
therapy with data reported until 12 months after the intervention.
To our surprise, this manuscript referred to the exact same
group of 178 patients as mentioned in their article published
previously this year, on the 1-month and 3-month follow-up of
clinical and QoL outcomes of their well performed RCT compar-
ing the three interventions.2
Although the current article includes the 12-month follow-up
assessments, it does not show us the results of the clinical and QoL
outcomes by allocated intervention, which is much more relevant
for clinical practice.
This is a missed opportunity because long-term follow-up in a
large group of patients with IC randomized in three different inter-
ventions has not been performed before, the studies in this field are
scarce and we would actually like to know what the most optimal
treatment strategy is for a patient with IC. Also, because only one
former publication focused on patients with IC due solely to femoro-
popliteal artery disease (comparing two interventions; supervised ex-
ercise with combined therapy) and they were unable to give a clear
answer owing to low recruitment rate and low rate of eligibility.3
In conclusion, QoL index scores are evidently an appropriate
tool for independent outcome reporting following interventions
for IC, but we do not see the newsworthiness of reporting QoL
changes after all interventions together. Despite our comment, we
certainly look forward to the long-term results of this study initi-
ated by the Academic Vascular Surgery Unit of the University of
Hull (http://ClinicalTrials.gov identifier: NCT00798850).
Franceline Alkine Frans, MD
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Mark J. W. Koelemay, MD, PhD
Department of Vascular Surgery
Academic Medical Center
Amsterdam, The Netherlands
c
wEFERENCES
. Mazari FA, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T,
et al. An analysis of relationship between quality of life indices and clinical
improvement following intervention in patients with intermittent clau-
dication due to femoropopliteal disease. J Vasc Surg 2010;52:77-84.
. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT,
et al. Early outcomes from a randomized, controlled trial of supervised
exercise, angioplasty, and combined therapy in intermittent claudication.
Ann Vasc Surg 2010;24:69-79.
. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al.
The adjuvant benefit of angioplasty in patients with mild to moderate
intermittent claudication (MIMIC) managed by supervised exercise,
smoking cessation advice and best medical therapy: results from two
randomised trials for stenotic femoropopliteal and aortoiliac arterial
disease. Eur J Vasc Endovasc Surg 2008;36:680-8.
oi:10.1016/j.jvs.2010.11.132
eply
We appreciate and welcome the comments made by Dr Frans
nd Dr Koelemay regarding our article and would like to address
he issues they raised, one by one:
First, we clearly mentioned in the Methods section that this
as an observational study that recruited patients from an ongoing
andomized controlled trial (RCT). This is the largest RCT to date
n claudicant patients with femoropopliteal disease and has many
ubsidiary studies running alongside. Because the study under
onsideration was purely observational, no sample size calculations
ere performed, and we aimed to maximize the recruitment to get
eliable and robust results. In this particular instance, all trial
articipants consented to take part in the study and were included
n the final analysis.
Second, there is a dearth of studies reporting the relationship
etween quality-of-life (QOL) indexes and clinical indicators, as
entioned in the introduction and in the Discussion section.
ecause these indexes are commonly used in economic analyses, it
s important to study and establish their relationship, and the study
as conducted to answer this specific question in all treatment
roups. Therefore, subgroup analysis was not performed as a part
f this study. Furthermore, subgroup analysis of QOL indicators is
ncluded in the results of the RCT and, therefore, cannot be
resented in this particular article.
Third, the findings of this study provide evidence to use
omposite outcome measures, including clinical and QOL indica-
ors in future studies, regardless of the treatments. This, in our
iew, was worthy of reporting to the scientific community. This
iew was clearly shared by our peers who reviewed the manuscript
nd found it worthy of publication in this esteemed journal.
And finally, the final results of the RCT are currently under
eview for publication, and we hope that they will provide the
nswers that Dr Frans and Dr Koelemay are looking for.
ayyaz Ali Khan Mazari, MBBS, MRCS
an C. Chetter, MBChB, FRCS
on behalf of all the authors)
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he Swedish experience of screening for abdominal
ortic aneurysm
Ruptured abdominal aortic aneurysm (AAA) is a common
ause of death among elderly men. Early detection by screening
ith ultrasound and prophylactic surgery in appropriately selected
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Volume 53, Number 4 Letters to the Editor 1165individuals has by randomized trials been established the most
effective method to reduce the high mortality.1,2
In the United States, screening for AAA is delivered through
Medicare since 2007. A single scan is offered to men aged 65 to 75
who have ever smoked. However, due to regulatory restrictions,
the utilization of the program has so far been limited. A similar
program is offered through the US Department of Veteran Affairs,
and various privately-funded AAA screening programs exist. In the
United Kingdom, a nationally coordinated screening program was
launched in 2009 which provides for a single scan of men aged 65,
and it is anticipated that nationwide coverage will be achieved by
2013.
In Sweden, with a total population of 9.2million, 700 to 1000
deaths are annually attributed to ruptured AAA. Following the
introduction of a general AAA-screening program for 65-year-old
men in the County of Uppsala in 2006, most counties in Sweden
have started similar programs. Today, more than 90% of all 65-
year-old men in Sweden are included in a screening program.
Thereby, Sweden is the first country with a practically nationwide
coverage.
The public healthcare system in Sweden is run by 21 indepen-
dent counties: each decides autonomously whether screening
should be introduced or not and how to design the program. With
the exchange of ideas and experiences within the medical profes-
sion, it has still been possible to harmonize the design and meth-
odology throughout the country. Most counties have adopted a
centralized hospital-based screening program to which all 65-year-
old men, identified through the National Population Registry, are
invited. The attendance rates have been high as about 85%.
The baseline examination includes a single ultrasound scan
where the maximum infrarenal anteroposterior diameter is mea-
sured according to the “leading edge to leading edge” principle
with the ultrasound (US) transducer longitudinally to the aorta. In
the Uppsala experience, a negative scan takes on average less than
4 minutes. With an examination fee of $20 (equal to that of
mammography screening), the screening program is close to self-
funded. The scan result is instantly communicated to the partici-
pant by the US technician, and subjects with a screening-detected dAA are scheduled for an appointment with a vascular surgeon or
urse.
No consensus has yet been reached as for the threshold
iameter for further follow-up. Some counties use 30 mm as the
ut-off diameter, which corresponds to the generally accepted
efinition of an AAA. Others use 25 mm as the cut-off diameter
ased on the results from contemporary reports indicating that an
orta between 25 and 29 mm should be classified as an “aneurysm
n formation.” Rescanning after 5 years has been recommended for
his subgroup.3 In Uppsala, 3.3% of those examined had an aorta
25 mm and 1.3% 30 mm.
Based on this experience, we conclude that a population-based
AA-screening program can be implemented in a simple way, at a
ow cost, and is well accepted by the population.
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